The Manufacturers Life Insurance Company Purchases 844 Shares of Xylem Inc. (NYSE:XYL)

The Manufacturers Life Insurance Company boosted its holdings in Xylem Inc. (NYSE:XYL) by 0.6% in the second quarter, HoldingsChannel reports. The institutional investor owned 153,978 shares of the industrial products company’s stock after purchasing an additional 844 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Xylem were worth $20,885,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. raised its stake in Xylem by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 28,048,996 shares of the industrial products company’s stock valued at $3,207,683,000 after purchasing an additional 187,847 shares during the period. Swedbank AB boosted its position in shares of Xylem by 1.0% during the second quarter. Swedbank AB now owns 2,436,974 shares of the industrial products company’s stock worth $330,527,000 after acquiring an additional 25,308 shares during the last quarter. Mirova US LLC grew its stake in Xylem by 2.0% during the second quarter. Mirova US LLC now owns 1,876,618 shares of the industrial products company’s stock valued at $254,526,000 after acquiring an additional 36,013 shares in the last quarter. DekaBank Deutsche Girozentrale increased its holdings in Xylem by 2.2% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 1,665,090 shares of the industrial products company’s stock valued at $227,364,000 after acquiring an additional 36,601 shares during the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lifted its stake in Xylem by 1,503.7% in the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 1,649,926 shares of the industrial products company’s stock worth $188,685,000 after purchasing an additional 1,547,043 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Stock Performance

Shares of NYSE:XYL opened at $134.39 on Wednesday. The company has a current ratio of 1.85, a quick ratio of 1.33 and a debt-to-equity ratio of 0.19. The company has a market capitalization of $32.58 billion, a price-to-earnings ratio of 47.83, a PEG ratio of 2.37 and a beta of 1.04. Xylem Inc. has a 12 month low of $87.59 and a 12 month high of $146.08. The firm’s 50-day moving average is $133.00 and its 200 day moving average is $134.58.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, July 30th. The industrial products company reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.04. Xylem had a return on equity of 9.48% and a net margin of 9.11%. The firm had revenue of $2.17 billion for the quarter, compared to the consensus estimate of $2.14 billion. During the same period in the prior year, the business posted $0.98 earnings per share. The company’s revenue for the quarter was up 26.0% on a year-over-year basis. Research analysts predict that Xylem Inc. will post 4.26 EPS for the current year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 26th. Stockholders of record on Thursday, August 29th were paid a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 1.07%. The ex-dividend date was Thursday, August 29th. Xylem’s dividend payout ratio is presently 51.25%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on XYL shares. TD Cowen reaffirmed a “hold” rating and issued a $138.00 target price on shares of Xylem in a report on Tuesday, September 3rd. Royal Bank of Canada upped their price objective on Xylem from $160.00 to $163.00 and gave the stock an “outperform” rating in a report on Wednesday, July 31st. Robert W. Baird raised their target price on shares of Xylem from $155.00 to $170.00 and gave the company an “outperform” rating in a report on Wednesday, July 31st. UBS Group initiated coverage on shares of Xylem in a report on Tuesday, August 13th. They issued a “buy” rating and a $165.00 target price on the stock. Finally, Stifel Nicolaus upped their target price on shares of Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. Five research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat, Xylem has an average rating of “Moderate Buy” and a consensus target price of $147.54.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.